This is a very important distinction
But I tell everyone, this is what we know today; tomorrow there may be new data that changes the discussion. Lamberton adds that the newer medications labeled specifically for weight loss use the same active ingredient as the original diabetes medications, which have been around for 15 years
Surprisingly, the study found the opposite: patients exposed to GLP-1 receptor agonists had a substantially higher risk of developing wet AMD and were diagnosed sooner than comparable patients not taking these medications
Patients in the dataset had a 2.56 times higher rate of developing NAION within 1 year after starting a GLP-1 receptor agonist than those in the dataset who started a dipeptidyl peptidase-4 (DPP-4) inhibitor
Semaglutide, a GLP-1 receptor agonist, is one of the innovative medications we offer to help our clients achieve their weight loss goals safely and sustainably
Below are examples of GLP-1 agonists commonly prescribed for diabetes or weight loss